Results 91 to 100 of about 622,361 (248)
Populations Addressed in Vaccines Approved via the European Medicines Agency
Clinical Pharmacology &Therapeutics, Volume 118, Issue 2, Page 459-469, August 2025.Therapeutic and prophylactic agents require robust evidence before patient use. Randomized controlled trials are essential for evaluating safety and efficacy but often exclude specific populations that are also targets for the intervention. This study assessed which populations are included in vaccine registration studies and/or addressed in label ...
Débora D. Gräf +3 more
wiley +1 more source
Polysaccharide pneumococcal vaccines
BMJ, 2002 Infection with Streptococcus pneumoniae (pneumococcus) is a leading cause of illness in young children and of illness and death in elderly people and people with immune deficiencies and chronic illness. Pneumococcus causes a spectrum of disease: infections of the upper respiratory tract, otitis media, invasive infections such as bacteraemia and ...
Vittorio Demicheli, Tom Jefferson
openaire +4 more sources
Nonencapsulated
mBio, 2016 While significant protection from pneumococcal disease has been achieved by the use of polysaccharide and polysaccharide-protein conjugate vaccines, capsule-independent protection has been limited by serotype replacement along with disease caused by ...
Lance E. Keller +2 more
doaj +1 more source
Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel
Emerging Infectious Diseases, 2013 Postlicensure surveillance of pneumonia incidence can be used to estimate whether pneumococcal conjugate vaccines (PCVs) affect incidence. We used Poisson regression models that control for baseline seasonality to determine the impact of PCVs and the ...
D. Weinberger +6 more
semanticscholar +1 more source
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 23, Issue 8, Page 925-930, August 2025.Summary The immunosuppressive and immunomodulatory treatment of dermatological patients necessitates the regular review and updating of standard vaccinations and vaccines indicated for specific conditions. The German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute regularly publishes evidence‐based vaccination recommendations ...
Johanna Stoevesandt +3 more
wiley +1 more source
Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough
Expert Review of Vaccines, 2015 Streptococcus pneumoniae is a major cause of childhood morbidity and mortality worldwide. A heptavalent polysaccharide-protein conjugate vaccine (PCV) has proven highly effective in preventing pneumococcal disease in industrialized countries.
William P. Hausdorff +2 more
semanticscholar +1 more source
The Journal of Clinical Hypertension, Volume 27, Issue 8, August 2025.ABSTRACT The protective effect of influenza vaccination on stroke risk has been inconclusive. In this study, we aimed to investigate the impact of influenza vaccination on the 1‐year risk of stroke in individuals aged 60 years and older with COPD and hypertension or diabetes mellitus.
Yuheng Wang +9 more
wiley +1 more source
Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
Human Vaccines & Immunotherapeutics, 2015 Infection due to Streptococcus pneumoniae is a leading cause of morbidity and mortality in young children, especially in developing countries. With the support of Gavi, the Vaccine Alliance, the majority of these countries have introduced pneumococcal ...
G. Rodgers, K. Klugman
semanticscholar +1 more source
The Nurse Practitioner's Immuniser Role in Primary Healthcare: A Scoping Review
Journal of Clinical Nursing, Volume 34, Issue 8, Page 3072-3084, August 2025.ABSTRACT Aim(s) This scoping review aimed to explore and identify literature about the scope of practice for nurse practitioners working as immunisers in primary healthcare. Design The review was conducted according to the JBI scoping review framework.
Christine Schoenfisch +2 more
wiley +1 more source
The New Era of Pneumococcal Vaccination in Adults: What Is Next?
VaccinesStreptococcus pneumoniae remains the leading cause of community-acquired pneumonia in adults and bacterial meningitis in children worldwide. In addition to pneumonia, invasive pneumococcal diseases (IPDs), such as bacteremia and meningitis, pose a ...
Lale Ozisik
doaj +1 more source